• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ryan Specialty Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    5/26/26 7:15:13 AM ET
    $RYAN
    Specialty Insurers
    Finance
    Get the next $RYAN alert in real time by email
    ryan-20260526
    FALSE000184925300018492532026-05-262026-05-26
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    ____________________
    FORM 8-K
    ____________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 26, 2026
    ____________________
    RYAN SPECIALTY HOLDINGS, INC.
    (Exact name of Registrant as Specified in Its Charter)
    ____________________
    Delaware
    001-40645
    86-2526344
    (State or Other Jurisdiction
    of Incorporation)
    (Commission File Number)
    (IRS Employer
    Identification No.)
    155 North Wacker Drive, Suite 4000
    Chicago, Illinois
    60606
    (Address of Principal Executive Offices)
    (Zip Code)
    Registrant’s Telephone Number, Including Area Code: 312 784-6001
    (Former Name or Former Address, if Changed Since Last Report)
    ____________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
    registrant under any of the following provisions:
    o
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    o
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    o
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    o
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading
    Symbol(s)
    Name of each exchange on which registered
    Class A Common Stock, $0.001 par value
    RYAN
    The New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
    of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    Emerging growth company o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
    period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
    Exchange Act. o
    Item 7.01 Regulation FD Disclosure.
    On May 26, 2026, Ryan Specialty Holdings, Inc. (the “Company”) issued a press release announcing that its Board of
    Directors has approved an increase to the Company's share repurchase program that authorizes the Company to repurchase
    up to an additional $300 million of its outstanding Class A common stock, bringing the total share repurchase program to
    $600 million. As of May 22, 2026, after accounting for the recent share repurchases during the second quarter of 2026 and
    for the increased authorization, there is $300 million of authorization remaining available under the program.
    Share repurchases may be made from time to time on the open market, in privately negotiated transactions, using Rule
    10b5-1 trading plans, as accelerated share repurchases, or in any other manner that complies with the applicable securities
    law. The timing of purchases and number of shares repurchased under the program will depend upon a variety of factors
    including the Company’s stock price, trading volume, working capital or other liquidity requirements, and market
    conditions. The Company is not obligated to purchase any shares under the program and the program may be suspended or
    discontinued at any time without notice.
    The press release is attached as Exhibit 99.1 and is incorporated herein by reference.
    The information furnished under Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18
    of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that
    section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as
    amended, or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing.
    Item 9.01 Financial Statements and Exhibits.
    (d)Exhibits.
    The following exhibits are furnished herewith:
    Exhibit No.
    Description of Exhibit
    99.1
    Press Release dated May 26, 2026
    104
    Cover Page Interactive Data File (formatted as inline XBRL)
    Cautionary Note Regarding Forward-Looking Statements
    This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of
    1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact included in this
    report, are forward-looking statements. Forward-looking statements give our current expectations relating to our financial
    condition, results of operations, plans, objectives, future performance, and business. You can identify forward-looking
    statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such
    as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,”
    and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating
    or financial performance or other events.  All forward-looking statements are subject to risks and uncertainties that may
    cause actual results to differ materially from those that we expected, These forward-looking statements are not guarantees
    of future performance and involve risks, assumptions and uncertainties, including, but not limited to, those relating to
    whether the Company will achieve the associated objectives with its Empower Program, whether the costs and charges
    associated with restructuring initiatives will exceed current estimates and forecasts, its ability to realize expected benefits in
    the amounts and at the times anticipated, changes in management’s assumptions, its ability to achieve anticipated financial
    results, risks associated with acquisitions, divestitures, joint ventures and strategic investments, outcomes of legal and
    regulatory matters, and changes in legislation or regulations. These and other risks, assumptions and uncertainties are
    described in Item 1A (Risk Factors) of the Company’s most recent Annual Report on Form 10-K and in other documents
    that the Company files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or
    uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those
    indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on
    these forward-looking statements, which speak only as of the date they are made. Except to the extent required by law, the
    Company does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking
    statement after the date of this report, whether as a result of new information, future events, changes in assumptions or
    otherwise.
    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
    on its behalf by the undersigned hereunto duly authorized.
    RYAN SPECIALTY HOLDINGS, INC. (Registrant)
    Date:
    May 25, 2026
    By:
    /s/ Mark S. Katz
    Mark S. Katz
    Executive Vice President, General Counsel and Corporate
    Secretary
    Get the next $RYAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RYAN

    DatePrice TargetRatingAnalyst
    5/1/2026$31.00Overweight → Equal Weight
    Wells Fargo
    3/17/2026$45.00Outperform
    RBC Capital Mkts
    2/25/2026$43.00Outperform → Market Perform
    BMO Capital Markets
    12/1/2025$64.00Hold
    Jefferies
    11/20/2025$60.00Neutral
    Piper Sandler
    9/17/2025$60.00Equal Weight → Overweight
    Wells Fargo
    9/16/2025$64.00Outperform
    Wolfe Research
    8/13/2025$61.00Neutral
    Cantor Fitzgerald
    More analyst ratings

    $RYAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ryan Specialty Group downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Ryan Specialty Group from Overweight to Equal Weight and set a new price target of $31.00

    5/1/26 7:31:21 AM ET
    $RYAN
    Specialty Insurers
    Finance

    RBC Capital Mkts initiated coverage on Ryan Specialty Group with a new price target

    RBC Capital Mkts initiated coverage of Ryan Specialty Group with a rating of Outperform and set a new price target of $45.00

    3/17/26 9:29:57 AM ET
    $RYAN
    Specialty Insurers
    Finance

    Ryan Specialty Group downgraded by BMO Capital Markets with a new price target

    BMO Capital Markets downgraded Ryan Specialty Group from Outperform to Market Perform and set a new price target of $43.00

    2/25/26 7:40:49 AM ET
    $RYAN
    Specialty Insurers
    Finance

    $RYAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Hamilton Janice M bought $200,293 worth of shares (6,300 units at $31.79), increasing direct ownership by 76% to 14,574 units (SEC Form 4)

    4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

    6/4/26 8:05:07 AM ET
    $RYAN
    Specialty Insurers
    Finance

    EVP & General Counsel Katz Mark Stephen bought $99,888 worth of shares (3,215 units at $31.07), increasing direct ownership by 288% to 4,332 units (SEC Form 4)

    4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

    6/4/26 8:04:28 AM ET
    $RYAN
    Specialty Insurers
    Finance

    Director Bienen Henry S gifted 5,757 units of Class A Common Stock, received a gift of 5,757 shares and gifted 2,700 shares, closing all direct ownership in the company (SEC Form 4)

    4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

    6/1/26 5:11:41 PM ET
    $RYAN
    Specialty Insurers
    Finance

    $RYAN
    SEC Filings

    View All

    Ryan Specialty Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Filer)

    5/26/26 7:15:13 AM ET
    $RYAN
    Specialty Insurers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Ryan Specialty Holdings Inc.

    SCHEDULE 13G/A - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)

    5/14/26 1:55:35 PM ET
    $RYAN
    Specialty Insurers
    Finance

    SEC Form SCHEDULE 13G filed by Ryan Specialty Holdings Inc.

    SCHEDULE 13G - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)

    5/13/26 3:48:07 PM ET
    $RYAN
    Specialty Insurers
    Finance

    $RYAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AM Best Assigns Performance Assessment to Ryan Specialty (Singapore) Pte. Limited; Affirms Performance Assessment of Remaining Ryan Specialty Underwriting Managers' Affiliates

    AM Best has assigned a Performance Assessment (assessment) of PA-1 (Exceptional) to Ryan Specialty (Singapore) Pte. Limited (Singapore). The outlook assigned to the assessment is stable. Concurrently, AM Best has affirmed the assessment of PA-1 (Exceptional) of the eight existing affiliates of Ryan Specialty Underwriting Managers (RSUM) (Chicago, IL). The outlook of the assessment is stable. The assessment reflects RSUM's exceptional underwriting capabilities, exceptional governance and internal controls, excellent financial condition, exceptional organizational talent and exceptional depth and breadth of relationships. In AM Best's view, the nine affiliated companies, which include 40

    6/2/26 12:31:00 PM ET
    $RYAN
    Specialty Insurers
    Finance

    Ryan Specialty to Participate in the William Blair Growth Stock Conference

    Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty"), a leading international specialty insurance services firm, today announced that it will be presenting at the William Blair Growth Stock Conference on Tuesday, June 2, 2026 at 9:40 AM Eastern Time. The presentation will be available via a link to the live stream accessible through Ryan Specialty's website at ir.ryanspecialty.com. A replay of the presentation will be available for 90 days following the conclusion of the event. About Ryan Specialty Founded in 2010, Ryan Specialty is a service provider of specialty products and solutions for insurance brokers, agents and carriers. The firm provides distribution, underwriting, p

    5/28/26 4:15:00 PM ET
    $RYAN
    Specialty Insurers
    Finance

    Ryan Specialty Announces $300 Million Increase to Share Repurchase Program

    Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty"), a leading international specialty insurance services firm, today announced that its Board of Directors on May 21, 2026 increased the authorization of its existing share repurchase program for shares of the Company's Class A common stock by $300 million. As of May 22, 2026, the Company repurchased $260 million of Class A common stock in the second quarter, exhausting its prior authorization of $300 million. After accounting for the increased authorization, there is $300 million of authorization remaining available under the current program. "The increased authorization of our share repurchase program reflects the Board's ongoi

    5/26/26 7:00:00 AM ET
    $RYAN
    Specialty Insurers
    Finance

    $RYAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Hamilton Janice M bought $200,293 worth of shares (6,300 units at $31.79), increasing direct ownership by 76% to 14,574 units (SEC Form 4)

    4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

    6/4/26 8:05:07 AM ET
    $RYAN
    Specialty Insurers
    Finance

    EVP & General Counsel Katz Mark Stephen bought $99,888 worth of shares (3,215 units at $31.07), increasing direct ownership by 288% to 4,332 units (SEC Form 4)

    4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

    6/4/26 8:04:28 AM ET
    $RYAN
    Specialty Insurers
    Finance

    Director Ryan Patrick G Jr bought $1,033,975 worth of shares (25,865 units at $39.98), increasing direct ownership by 0.14% to 256,559 units (SEC Form 4)

    4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

    2/24/26 5:15:41 PM ET
    $RYAN
    Specialty Insurers
    Finance

    $RYAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ryan Specialty Holdings Inc.

    SC 13G/A - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)

    11/13/24 4:05:17 PM ET
    $RYAN
    Specialty Insurers
    Finance

    SEC Form SC 13G filed by Ryan Specialty Holdings Inc.

    SC 13G - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)

    11/13/24 2:59:53 PM ET
    $RYAN
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by Ryan Specialty Holdings Inc. (Amendment)

    SC 13D/A - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Subject)

    3/14/24 5:00:31 PM ET
    $RYAN
    Specialty Insurers
    Finance

    $RYAN
    Leadership Updates

    Live Leadership Updates

    View All

    Ryan Specialty Appoints Stephen Stewart CEO of Ryan Specialty Canada Limited

    Ryan Specialty Completes Canadian Amalgamation Ryan Specialty (NYSE:RYAN), a leading international specialty insurance intermediary, is pleased to announce the appointment of Stephen Stewart, President & CEO of Stewart Specialty Risk Underwriting, a Ryan Specialty managing general underwriter, to the additional role Chief Executive Officer of Ryan Specialty Canada Limited, the newly formed Canadian operating and holding entity for Ryan Specialty's underwriting management businesses in Canada. Ryan Specialty Canada Limited is headquartered in Toronto. With the formation of its Canadian holding entity, Ryan Specialty completes the amalgamation of its Canadian operations, including the Can

    2/5/26 8:41:00 AM ET
    $RYAN
    Specialty Insurers
    Finance

    Ryan Specialty Appoints Steve Keogh and Brendan Mulshine as Co-Presidents

    Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty" or "the Company"), a leading international specialty insurance firm, today announced that Steve Keogh, Chief Operating Officer, and Brendan Mulshine, Chief Revenue Officer, have been appointed to the additional roles of Co-Presidents of Ryan Specialty. In their roles, Mr. Keogh and Mr. Mulshine will report to Chief Executive Officer, Tim Turner. They succeed Jeremiah Bickham, who has transitioned from his position as President to serve as a strategic advisor through the end of the year. "Steve and Brendan are seasoned insurance executives who have driven strong operational and financial results," said Pat Ryan, Ryan Specialty's F

    10/8/25 4:15:00 PM ET
    $RYAN
    Specialty Insurers
    Finance

    Ryan Specialty Appoints Michael G. Bungert, Distinguished (Re)Insurance Veteran, to Board of Directors

    Ryan Specialty Holdings, Inc. (NYSE:RYAN), a leading international specialty insurance firm, today announced that Michael G. Bungert, distinguished (re)insurance veteran, has been appointed to its Board of Directors and serves as a member of its Compensation and Governance Committee, effective September 3, 2025. "Mike has extensive insurance industry experience and knowledge, and we welcome his strategic insights and talent to the Ryan Specialty Board," said Patrick G. Ryan, Chairman of the Board of Directors. "We are looking forward to embracing Mike's contributions to our Board and to Ryan Specialty as a whole." "I am thrilled to join the Board of Ryan Specialty," added Mr. Bungert. "

    9/9/25 4:05:00 PM ET
    $RYAN
    Specialty Insurers
    Finance

    $RYAN
    Financials

    Live finance-specific insights

    View All

    Ryan Specialty to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026

    Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty"), a leading international specialty insurance firm, today announced it will release its First Quarter 2026 financial results after the market closes on Thursday, April 30, 2026. Ryan Specialty will hold a conference call to discuss the financial results at 4:45pm Eastern Time on April 30, 2026. Interested parties may access the conference call through the live webcast, which can be registered for via this link or by visiting the Company's Investor Relations website. Please join the live webcast at least 10 minutes prior to the scheduled start time. A webcast replay of the call will be available at ir.ryanspecialty.com for one y

    4/6/26 5:37:00 PM ET
    $RYAN
    Specialty Insurers
    Finance

    Ryan Specialty Reports Fourth Quarter 2025 Results

    - Total Revenue grew 13.2% year-over-year to $751.2 million - - Organic Revenue Growth Rate* of 6.6% year-over-year - - Net Income of $31.2 million, or $0.06 per diluted share - - Adjusted EBITDAC* grew 2.9% year-over-year to $222.3 million - - Adjusted Net Income increased 0.5% year-over-year to $124.0 million - - Adjusted Diluted Earnings Per Share was $0.45 per diluted share - - Company Announces $300 million Share Repurchase Authorization - Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty" or the "Company"), a leading international specialty insurance firm, today announced results for the fourth quarter ended December 31, 2025. Fourth Quarter 2025 Highlights

    2/12/26 4:05:00 PM ET
    $RYAN
    Specialty Insurers
    Finance

    Ryan Specialty to Announce Fourth Quarter 2025 Financial Results on Thursday, February 12, 2026

    Ryan Specialty Holdings, Inc. (NYSE:RYAN) ("Ryan Specialty"), a leading international specialty insurance firm, today announced it will release its Fourth Quarter 2025 financial results after the market closes on Thursday, February 12, 2026. Ryan Specialty will hold a conference call to discuss the financial results at 5:00pm Eastern Time on February 12, 2026. Interested parties may access the conference call through the live webcast, which can be accessed via this link or by visiting the Company's Investor Relations website. Please join the live webcast at least 10 minutes prior to the scheduled start time. A webcast replay of the call will be available at ir.ryanspecialty.com for one

    1/12/26 4:15:00 PM ET
    $RYAN
    Specialty Insurers
    Finance